434 articles – 313 Notices  [english version]
Fiche concise
The Data from an Epidemiologic Study on the Insulin Resistance Syndrome Study: the change and the rate of change of the age-blood pressure relationship.
Safar M. E., Lange C., Tichet J., Blacher J., Eschwège E., Balkau B., Study Group T. D.
Journal of Hypertension 26, 10 (2008) 1903-1911 - http://www.hal.inserm.fr/inserm-00292150
(18806613)
The Data from an Epidemiologic Study on the Insulin Resistance Syndrome Study: the change and the rate of change of the age-blood pressure relationship.
Michel Safar1, Céline Lange2, Jean Tichet3, Jacques Blacher1, Eveline Eschwège2, Beverley Balkau () 2, The Desir Study Group3
1 :  Centre de diagnostic
Assistance publique - Hôpitaux de Paris (AP-HP) – Hôtel-Dieu – Université Paris V - Paris Descartes
France
2 :  Recherche en épidémiologie et biostatistique
INSERM : IFR69 – Université Paris XI - Paris Sud
16, Avenue Paul Vaillant-Couturier 94807 VILLEJUIF CEDEX
France
3 :  IRSA - Institut inter Régional pour la SAnté
Centre de Prévention et de Santé Publique de Tours - La Riche
45 rue de la Parmentière 37 521 La Riche Cedex
France
Rate of change of the age-blood pressure relationship
OBJECTIVE: Systolic blood pressure (SBP) and diastolic blood pressure (DBP) increase significantly until around 55 years, when SBP increases, DBP decreases. Whether the rates of change of SBP and DBP with age exhibit a similar dissociation has never been investigated. DESIGN AND PARTICIPANTS: The Data from an Epidemiologic Study on the Insulin Resistance Syndrome Study (D.E.S.I.R.), a 9-year longitudinal study included 2278 men and 2314 women, 30-65 years and SBP, DBP, and other cardiometabolic risk factors were determined every 3 years. RESULTS: Both SBP and DBP increased with age, more rapidly in women than in men. SBP and DBP were higher in the presence of risk factors (except smoking) but the increases with age were similar. For the rates of change, whereas DeltaSBP increased linearly with age, DeltaDBP declined as early as 45 years. This finding was not influenced by sex, menopause or other risk factors but was significantly attenuated in the presence of hypertension at baseline, whether treated or not, and mainly in men. CONCLUSION: DBP increases with age between 30 and 60 years, DeltaDBP tends to be markedly reduced as early as 45 years, in contrast with DeltaSBP. Consequences for the understanding of vascular aging and antihypertensive therapy remain to be explored.
Sciences du Vivant/Santé publique et épidémiologie
Anglais
0263-6352

Articles dans des revues avec comité de lecture
10.1097/HJH.0b013e32830b8937
Journal of Hypertension (J Hypertens)
Publisher Lippincott, Williams & Wilkins
ISSN 0263-6352 
internationale
10/2008
26
10
1903-1911

INSERM, CNAMTS, Lilly, Novartis Pharma, Sanofi-Aventis, Association Diabète Risque Vasculaire, Fédération Française de Cardiologie,La Fondation de France, ALFEDIAM, ONIVINS, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Santé, Novo Nordisk, Pierre Fabre, Roche, Topcon